Helen Tayton Martin

Insider Reports History

Entity
Individual
Location
C/O Adaptimmune Therapeutics Plc, 60 Jubilee Ave, Milton Park, Abingdon, Oxfordshire, United Kingdom
Signature
/s/ Helen Tayton-Martin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Helen Tayton Martin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Adaptimmune Therapeutics PLC Chief Business & Strgy Officer Option to purchase Ordinary Shares 565K Jan 15, 2024 Direct
Trillium Therapeutics Inc. Director Deferred Share Unit 0 Nov 17, 2021 Direct
Trillium Therapeutics Inc. Director Stock Option (Right to Buy) 0 Nov 17, 2021 Direct

Insider Reports Filed by Helen Tayton Martin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ADAP Adaptimmune Therapeutics PLC Jan 15, 2024 2 $0 4 Jan 17, 2024 Chief Business & Strgy Officer
ADAP Adaptimmune Therapeutics PLC Jan 17, 2023 3 $0 4 Jan 17, 2023 Chief Business & Strgy Officer
ADAP Adaptimmune Therapeutics PLC Jan 12, 2022 2 $0 4 Jan 13, 2022 Chief Business Officer
TRIL Trillium Therapeutics Inc. Nov 17, 2021 2 $0 4 Nov 19, 2021 Director